Population studies have reported that proton-pump inhibitors (PPIs) increase cardiovascular mortality, at least in part owing to an increased propensity for life-threatening arrhythmias, but these findings have largely been ignored. We propose a series of recommendations for prescribers of PPIs to ensure a balance of the benefits against the potential arrhythmic risks.

中文翻译：

---

质子泵抑制剂的促心律失常电位


人群研究报告称，质子泵抑制剂 （PPI） 会增加心血管死亡率，至少部分原因是危及生命的心律失常倾向增加，但这些发现在很大程度上被忽视了。我们为 PPI 的处方者提出了一系列建议，以确保在益处与潜在的心律失常风险之间取得平衡。